Skip to main content

Animations

Funded Studies

The Foundation supports research across basic, translational and clinical science to speed breakthroughs that can lead to the creation of new treatments and a better quality of life for people with Parkinson's disease.

Search or browse funded studies

Previously funded studies appear chronologically, with the most recent appearing first.

Filters
From
To
  • ${value}

Filter Results (2440${count})

  • LRRK2 Tools and Animal Models, 2018
    Tools for Studying Proteins LRRK2 and Rab35

    Study Rationale:
    Mutations in the LRRK2 gene are a leading genetic cause of Parkinson's disease (PD). One important function of the LRRK2 protein is to modify other proteins. Previously, we found that...

  • Research Grant, 2018
    Studying Changes in Glucocerebrosidase Activity in People with Parkinson's Disease

    Study Rationale:
    A dysfunction of the glucocerebrosidase (GCase) protein increases the risk of Parkinson's disease (PD). Blood cells called monocytes produce large amounts of this protein. The aim of...

  • Biosample Use Program, 2018
    MicroRNAs as Predictors and Measures of Parkinson's Disease

    Study Rationale:
    MicroRNAs (miRNAs) are molecules that control the production of proteins from genes in the cell. We have found that the blood of people with Parkinson's disease (PD) contains a lower...

  • Research Grant, 2018
    Inflammatory Phenotypes in Differentiated Human LRRK2 and GBA Mutation IPS Cell Lines

    Promising Outcomes of Original Grant:
    With previous funding from MJFF, we determined how the activity of LRRK2 genetic mutations contributed to inflammation in Parkinson's. We found that inflammation...

  • Research Grant, 2018
    Assess p935 LRRK2 and Total LRRK2 Levels Using an MSD Assay in Whole Blood

    Study Rationale:
    Some variants in the LRRK2 gene have been linked to increased risk of Parkinson's disease. This has made LRRK2 a promising target for Parkinson's drug development. To increase our...

  • Research Grant, 2018
    Autologous Long-Term Cell Restorative Therapy for Parkinson's Disease

    Study Rationale:
    Cell replacement using induced pluripotent stem cells (iPSCs) is a potential restorative therapy for Parkinson's disease. Replacing brain cells that produce dopamine, a chemical...

Two female doctors talking in the lab.

Apply for a Grant

Our funding programs support basic, translational and clinical research from academia and industry.

See Funding Opportunities
We use cookies to ensure that you get the best experience. By continuing to use this website, you indicate that you have read our Terms of Service and Privacy Policy.